52.2441027, 0.108049

Sovereign House, Chivers Way,
Vision Park, Histon,
Cambridge, CB24 9BZ, United Kingdom

GW Pharmaceuticals Plc

About Us

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.
GWPH
GW Pharmaceuticals Plc
168.610
USD
0.71
(0.42%)